Skip to main content
. 2015 Oct 8;26(9-10):486–500. doi: 10.1007/s00335-015-9603-x

Fig. 1.

Fig. 1

Overview of ENU mutation detection methods used on DNA-Seq data. Method 1 Male C57BL/6J mice mutagenized with ENU are bred to produce 50–100 third generation (G3) mice carrying mutations mostly in the heterozygous state. The G1 male founder of each pedigree is sent for whole genome sequencing. The G3 mice are put through a phenotyping screen and affected mice are genotyped with a SNP panel to identify ENU regions. Specific ENU SNPs within the candidate region are validated via Sanger Sequencing. After secondary phenotyping and inheritance testing a copy of the potential causative mutation may be generated with CRISPR/Cas9 targeting. Method 2 Two C57BL/6J mice are mutageneised with ENU, each are paired with WT C57BL/6J females to produce third generation mice carrying 4 possible haplotypes, ENU1, ENU2, WT1 and WT2. After phenotype testing 3 phenovariant G3 mice are sent for low coverage whole genome sequencing. Shared homozygous ENU variants seen in all 3 mice cluster in an IBD region, detected using the Lander-Green algorithm. Coding variants within the IBD are validated via Sanger Sequencing. Alternative alleles may be generated using CRISPR/Cas9 targeting. Method 3 Male C57BL/6J mice mutagenized with ENU are bred to produce 30–50 third generation (G3) mice carrying mutations in homozygous and heterozygous state. The G1 male founder of each pedigree is subjected to exome sequencing, and data are used to generate Ampliseq panel primers for amplification of mutated loci from G2 and G3 mouse DNA, followed by Ion PGM 200-bp sequencing. Genotyping data are uploaded to Mutagenetix prior to phenotypic screening. Quantitative phenotype data are entered into Mutagenetix and used with genotype data for mapping by Linkage Analyzer. Calculated P values for non-linkage, Manhattan plots, and scatter plots of phenotypic data for every mutant allele are displayed by Linkage Explorer. Confirmation of candidate genes depends on duplication of the mutant phenotype by a second allele, which may be generated by CRISPR/Cas9 targeting